Improved progression-free survival in multiple myeloma patients following three-drug therapy with autologous stem cell transplant



Improved progression-free survival in multiple myeloma patients following three-drug therapy with autologous stem cell transplant

Patients with multiple myeloma who have been treated with a three-drug combination therapy have a growing number of choices for subsequent treatment. Results of a new study can help patients and their physicians weigh benefits and risks of each option.

Materials provided by Dana-Farber Cancer Institute. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

31st March 2023

Form is (mal)function: Protein's shape lets bacteria disarm it

Read more
30th March 2023

Researchers discover a way to fight the aging process and cancer development

Read more
30th March 2023

Researchers identify cell type that could be key to preventing marrow transplant complication

Read more